Internal Medicine
Retrospective study | Supernumerary sex chromosome aneuploidies are associated with increased risk of VTE
18 Jan, 2023 | 14:22h | UTCAssociation of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism – JAMA (free for a limited period)
Review | Organization-wide approaches to foster effective unit-level efforts to improve clinician well-being
18 Jan, 2023 | 14:19h | UTC
Cohort Study | Hydroxychloroquine dose and risk for incident retinopathy
18 Jan, 2023 | 14:21h | UTCHydroxychloroquine Dose and Risk for Incident Retinopathy: A Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Long-term low-dose hydroxychloroquine use associated with low risk for retinopathy – American College of Physicians
Commentary: Long-term low-dose hydroxychloroquine use associated with low risk for retinopathy – ACP Internist
SR | Pre‐emptive antifungal therapy vs. empirical antifungal therapy for febrile neutropenia in people with cancer
18 Jan, 2023 | 14:18h | UTC
State of the Art Review | Telemental health for clinical assessment and treatment
17 Jan, 2023 | 13:29h | UTCTelemental health for clinical assessment and treatment – The BMJ
Commentary on Twitter
Telemental health use increased substantially and globally during the pandemic, however, the prevalence of its use has varied widely.
What do we know about the efficacy of telemental health for treatment and what do guidelines say on best practice?https://t.co/AqHKMkKNIV
— The BMJ (@bmj_latest) January 16, 2023
M-A | Increased risk of acute myocardial infarction after COVID-19 recovery
17 Jan, 2023 | 13:22h | UTC
Development and validation of a risk stratification tool for patients with Type 2 Myocardial Infarction
17 Jan, 2023 | 13:23h | UTCCommentary: Improving Risk Stratification for Patients With Type 2 MI – American College of Cardiology
Commentary on Twitter
T2-risk score was developed and validated to prognosticate outcomes (subsequent MI and death from any cause or death from CVD at 1 year) using clinical variables among patients w/ Type 2 MI. Get the study details: https://t.co/OqFdYj9bW6 #HeartFailure
— American College of Cardiology (@ACCinTouch) January 13, 2023
Impact of SARS-CoV-2 variants on inpatient clinical outcome
17 Jan, 2023 | 13:21h | UTCImpact of SARS-CoV-2 variants on inpatient clinical outcome – Clinical Infectious Diseases
AGA clinical practice update on diagnosis and management of acute hepatic porphyrias
17 Jan, 2023 | 13:19h | UTC
Podcast | Adrenal incidentalomas
17 Jan, 2023 | 13:16h | UTC#377 Adrenal Incidentalomas with Dr. William Young – The Curbsiders
Review | Difficult diagnosis in the ICU: making the right call but beware uncertainty and bias
17 Jan, 2023 | 13:02h | UTCDifficult diagnosis in the ICU: making the right call but beware uncertainty and bias – Anaesthesia
Review | Viral infections in critical care
17 Jan, 2023 | 13:01h | UTCViral infections in critical care: a narrative review – Anaesthesia
2023 ASA Guidelines for preoperative fasting
15 Jan, 2023 | 20:42h | UTC
WHO updates COVID-19 guidelines on masks, treatments and patient care
15 Jan, 2023 | 20:44h | UTCWHO updates COVID-19 guidelines on masks, treatments and patient care – World Health Organization
WHO Updated Guidelines:
Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization
Cohort Study | Adverse events identified in nearly one in four hospital admissions
15 Jan, 2023 | 20:40h | UTCThe Safety of Inpatient Health Care – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Nearly 1 in 4 Hospital Patients Have Harmful Event During Their Stay – HealthDay
Commentary on Twitter
A retrospective cohort study assessed patient safety in 11 Massachusetts hospitals in 2018. Adverse events were identified in 24% of hospital admissions and preventable adverse events in 7%. https://t.co/o4JM4JbxSF pic.twitter.com/yPSnvXM5IR
— NEJM (@NEJM) January 13, 2023
RCT | Fluvoxamine no better than placebo in outpatients with mild to moderate COVID-19
15 Jan, 2023 | 20:37h | UTCEditorial: Lack of Benefit of Fluvoxamine for COVID-19 – JAMA
Author Interview: Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19 – JAMA
Commentary: Trial finds that fluvoxamine doesn’t speed COVID recovery – CIDRAP
Commentary on Twitter
Among outpatients with mild to moderate #COVID19, treatment with 50 mg of fluvoxamine twice daily for 10 days, compared with placebo, did not improve time to sustained recovery. https://t.co/4QgBssqFSU pic.twitter.com/RMZ6mqlx6u
— JAMA (@JAMA_current) January 12, 2023
Best infectious diseases articles from 2022 – A year end review of non-COVID literature
15 Jan, 2023 | 20:31h | UTC
Commentary on Twitter
🔥🔥NEW 🔥🔥
Our new post, a great collaboration w 🌟 @IDstewardship
Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature
1️⃣7️⃣⚡️🆔 RCTs @NEJM @TheLancet ✨
2️⃣syst Rev
3️⃣🌏Guidelines @Wiki_Guidelines
#IDTwitter #TwitteRxhttps://t.co/JL07NLa3BV pic.twitter.com/Qcf2cwK8Sd— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) January 4, 2023
M-A | Effect of breathwork on stress and mental health
15 Jan, 2023 | 20:28h | UTC
Commentary on Twitter
A meta-analysis in @SciReports shows that breathwork may be effective for improving stress and mental health. The authors also call for nuanced research approaches with low risk-of-bias study designs to avoid a miscalibration between hype and evidence. https://t.co/iTLGE2AsPT pic.twitter.com/SM5FBL2idK
— Nature Portfolio (@NaturePortfolio) January 12, 2023
ESMO Guideline | Venous thromboembolism in cancer patients
15 Jan, 2023 | 20:21h | UTCVenous thromboembolism in cancer patients: ESMO Clinical Practice Guideline – Annals of Oncology
Related:
Cancer-associated venous thromboembolism – Nature Reviews Disease Primers
Infographic: Cancer-associated venous thromboembolism – Nature Reviews Disease Primers
NCCN Guideline: Cancer-Associated Venous Thromboembolic Disease.
ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer
Review: venous and arterial thromboembolism in patients with cancer.
SR | Baclofen for alcohol use disorder
15 Jan, 2023 | 20:11h | UTCBaclofen for alcohol use disorder – Cochrane Library
Summary: Baclofen for alcohol use disorder – Cochrane Library
Synopsis | Endocrine Society hypercalcemia of malignancy guidelines
15 Jan, 2023 | 22:13h | UTCEndocrine Society Hypercalcemia of Malignancy Guidelines – JAMA Oncology (free for a limited period)
Original article: Guideline | Treatment of hypercalcemia of malignancy in adults
M-A | Effectiveness of outpatient geriatric rehabilitation after inpatient geriatric rehabilitation or hospitalization
15 Jan, 2023 | 19:48h | UTC
Review | End-of-life care in the intensive care unit
15 Jan, 2023 | 19:39h | UTCEnd-of-life care in the intensive care unit – Anaesthesia
Retrospective Study | Most patients with long Covid developed after mild infection get better within a year
13 Jan, 2023 | 13:42h | UTCLong covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study – The BMJ
News Release: Most long COVID effects resolve within a year after mild infection, finds study- British Medical Journal
Commentary: Long COVID After Mild Infection? It Fades Within a Year – HealthDay
SR | Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression
13 Jan, 2023 | 13:37h | UTC
Commentary on Twitter
Read the latest #systematicreview of reviews and meta-narrative synthesis that looks at the dose efficiacy and tolerability of selective #serotonin reuptake inhibitors for #depression ▶️ https://t.co/B4lLe8YhcH pic.twitter.com/xIhz8sciJD
— BMJMedicine (@BMJMedicine) December 23, 2022